TY - JOUR AU - Bray, F. AU - Ferlay, J. AU - Soerjomataram, I. AU - Siegel, R. L. AU - Torre, L. A. AU - Jemal, A. PY - 2018 DA - 2018// TI - Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries JO - CA Cancer J Clin VL - 68 UR - https://doi.org/10.3322/caac.21492 DO - 10.3322/caac.21492 ID - Bray2018 ER - TY - JOUR AU - Cumberbatch, M. G. K. AU - Jubber, I. AU - Black, P. C. AU - Esperto, F. AU - Figueroa, J. D. AU - Kamat, A. M. PY - 2018 DA - 2018// TI - Epidemiology of bladder Cancer: a systematic review and contemporary update of risk factors in 2018 JO - Eur Urol VL - 74 UR - https://doi.org/10.1016/j.eururo.2018.09.001 DO - 10.1016/j.eururo.2018.09.001 ID - Cumberbatch2018 ER - TY - JOUR AU - Chang, S. S. AU - Boorjian, S. A. AU - Chou, R. AU - Clark, P. E. AU - Daneshmand, S. AU - Konety, B. R. PY - 2016 DA - 2016// TI - Diagnosis and treatment of non-muscle invasive bladder Cancer: AUA/SUO guideline JO - J Urol VL - 196 UR - https://doi.org/10.1016/j.juro.2016.06.049 DO - 10.1016/j.juro.2016.06.049 ID - Chang2016 ER - TY - STD TI - Institute of Medicine. Clinical Practice Guidelines We Can Trust. Washington, DC: The National Academies Press; 2011. https://doi.org/10.17226/13058. Accessed 12 Jan 2019. ID - ref4 ER - TY - JOUR AU - Woldu, S. L. AU - Bagrodia, A. AU - Lotan, Y. PY - 2017 DA - 2017// TI - Guideline of guidelines: non-muscle-invasive bladder cancer JO - BJU Int VL - 119 UR - https://doi.org/10.1111/bju.13760 DO - 10.1111/bju.13760 ID - Woldu2017 ER - TY - STD TI - The AGREE Collaboration. Appraisal of Guidelines for Research and Evaluation (AGREE-II) instrument. https://doi.org/10.17226/13058. Accessed 12 Jan 2019. ID - ref6 ER - TY - BOOK AU - Fleiss, J. L. PY - 1981 DA - 1981// TI - Statistical methods for rates and proportions PB - Wiley CY - New York ID - Fleiss1981 ER - TY - JOUR AU - Bellmunt, J. AU - Orsola, A. AU - Leow, J. J. PY - 2014 DA - 2014// TI - Bladder cancer: ESMO Practice Guidelines for diagnosis, treatment and follow-up JO - Ann Oncol VL - 25 UR - https://doi.org/10.1093/annonc/mdu223 DO - 10.1093/annonc/mdu223 ID - Bellmunt2014 ER - TY - STD TI - National Institute for Health and Care Excellence. Bladder cancer: diagnosis and management. National Institute for Health and Care Excellence February 2015. https://www.nice.org.uk/guidance/ng2. Accessed 12 Jan 2019. UR - https://www.nice.org.uk/guidance/ng2 ID - ref9 ER - TY - JOUR AU - Kassouf, W. AU - Traboulsi, S. L. AU - Kulkarni, G. S. AU - Breau, R. H. AU - Zlotta, A. PY - 2015 DA - 2015// TI - Fairey, et al. CUA guidelines on the management of non-muscle invasive bladder cancer JO - Can Urol Assoc J VL - 9 UR - https://doi.org/10.5489/cuaj.3320 DO - 10.5489/cuaj.3320 ID - Kassouf2015 ER - TY - JOUR AU - Kubota, Y. AU - Nakaigawa, N. PY - 2016 DA - 2016// TI - Essential content of evidence-based clinical practice guidelines for bladder cancer: the Japanese Urological Association 2015 update JO - Int J Urol VL - 23 UR - https://doi.org/10.1111/iju.13141 DO - 10.1111/iju.13141 ID - Kubota2016 ER - TY - STD TI - Babjuk M, Burger M, Compérat E, Gontero P, Mostafid AH, Palou J, et al. EAU Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1 and CIS). https://uroweb.org/guideline/non-muscle-invasive-bladder-cancer/. Accessed 12 Jan 2019. UR - https://uroweb.org/guideline/non-muscle-invasive-bladder-cancer/ ID - ref12 ER - TY - JOUR AU - Monteiro, L. L. AU - Witjes, J. A. AU - Agarwal, P. K. AU - Anderson, C. B. AU - Bivalacqua, T. J. AU - Bochner, B. H. PY - 2019 DA - 2019// TI - ICUD-SIU International consultation on bladder Cancer 2017: management of non-muscle invasive bladder cancer JO - World J Urol VL - 37 UR - https://doi.org/10.1007/s00345-018-2438-9 DO - 10.1007/s00345-018-2438-9 ID - Monteiro2019 ER - TY - JOUR AU - Jin, Y. H. AU - Zeng, X. T. PY - 2018 DA - 2018// TI - Chinese evidence-based clinical practice guidelines for treatment and surveillance of non-muscle-invasive bladder cancer (simplified version, 2018) JO - J Evid Based Med VL - 18 ID - Jin2018 ER - TY - STD TI - Flaig TW, Spiess PE, Agarwal N, Bangs R, Boorjian SA, Buyyounouski MK, et al. NCCN Clinical Practice Guidelines in Oncology: Bladder Cancer Version 1.2019 - December 20, 2018. https://www.nccn.org/professionals/physician_gls/default.aspx. Accessed 12 Jan 2019. UR - https://www.nccn.org/professionals/physician_gls/default.aspx ID - ref15 ER - TY - BOOK PY - 2012 DA - 2012// TI - Developing NICE guidelines: the manual PB - National Institute for Health and Care Excellence (NICE) CY - London ID - ref16 ER - TY - JOUR AU - Jin, Y. H. AU - Zeng, X. T. AU - Liu, T. Z. AU - Gong, K. AU - He, D. L. AU - Wang, X. H. PY - 2018 DA - 2018// TI - Evidence-based clinical practice guideline of treatment and surveillance for non-muscle-invasive bladder cancer-protocol JO - J Chin Res Hosp VL - 5 ID - Jin2018 ER - TY - JOUR AU - Rosenfeld, R. M. AU - Shiffman, R. N. AU - Robertson, P. PY - 2009 DA - 2009// TI - Clinical practice guideline development manual, third edition a quality-driven approach for translating evidence into action JO - Otolaryngol Head Neck Surg VL - 140 UR - https://doi.org/10.1016/j.otohns.2008.11.024 DO - 10.1016/j.otohns.2008.11.024 ID - Rosenfeld2009 ER - TY - JOUR AU - Alonso-Coello, P. AU - Irfan, A. AU - Solà, I. AU - Gich, I. AU - Delgado-Noguera, M. AU - Rigau, D. PY - 2010 DA - 2010// TI - The quality of clinical practice guidelines over the last two decades: a systematic review of guideline appraisal studies JO - Qual Saf Health Care VL - 19 ID - Alonso-Coello2010 ER - TY - STD TI - World Health Organization. WHO handbook for guideline development - 2nd ed. WHO Press; 2014. Available at: http://www.who.int. Accessed 12 Jan 2019. UR - http://www.who.int ID - ref20 ER - TY - STD TI - Scottish Intercollegiate Guidelines Network (SIGN). SIGN 50: a guideline developer’s handbook. Edinburgh: SIGN, 2015. (SIGN publication no. 50). [November 2015]. http://www.sign.ac.uk. Accessed 12 Jan 2019. UR - http://www.sign.ac.uk ID - ref21 ER - TY - JOUR AU - Rentsch, C. A. AU - Birkhäuser, F. D. AU - Biot, C. AU - Gsponer, J. R. AU - Bisiaux, A. AU - Wetterauer, C. PY - 2014 DA - 2014// TI - Bacillus Calmette-Guérin strain differences have an impact on clinical outcome in bladder Cancer immunotherapy JO - Eur Urol VL - 66 UR - https://doi.org/10.1016/j.eururo.2014.02.061 DO - 10.1016/j.eururo.2014.02.061 ID - Rentsch2014 ER - TY - JOUR AU - Sengiku, A. AU - Ito, M. AU - Miyazaki, Y. AU - Sawazaki, H. AU - Takahashi, T. AU - Ogura, K. PY - 2013 DA - 2013// TI - A prospective comparative study of Intravesical Bacillus Calmette-Guérin therapy with the Tokyo or Connaught strain for nonmuscle invasive bladder Cancer JO - J Urol VL - 190 UR - https://doi.org/10.1016/j.juro.2013.01.084 DO - 10.1016/j.juro.2013.01.084 ID - Sengiku2013 ER - TY - JOUR AU - Shepherd, A. R. AU - Shepherd, E. AU - Brook, N. R. PY - 2017 DA - 2017// TI - Intravesical Bacillus Calmette-Guerin with interferon-alpha versus intravesical Bacillus Calmette-Guerin for treating non-muscle-invasive bladder cancer JO - Cochrane Database Syst Rev VL - 3 ID - Shepherd2017 ER - TY - JOUR AU - Marttila, T. AU - Järvinen, R. AU - Liukkonen, T. AU - Rintala, E. AU - Boström, P. AU - Seppänen, M. PY - 2016 DA - 2016// TI - Intravesical Bacillus Calmette-Guérin versus combination of Epirubicin and interferon-α2a in reducing recurrence of non-muscle-invasive bladder carcinoma: FinnBladder-6 study JO - Eur Urol VL - 70 UR - https://doi.org/10.1016/j.eururo.2016.03.034 DO - 10.1016/j.eururo.2016.03.034 ID - Marttila2016 ER - TY - JOUR AU - Cui, J. AU - Wang, W. AU - Chen, S. AU - Chen, P. AU - Yang, Y. AU - Guo, Y. PY - 2016 DA - 2016// TI - Combination of Intravesical Chemotherapy and Bacillus Calmette–Guerin Versus Bacillus Calmette–Guerin Monotherapy in Intermediate- and High-risk Nonmuscle Invasive Bladder Cancer JO - Medicine VL - 95 UR - https://doi.org/10.1097/MD.0000000000002572 DO - 10.1097/MD.0000000000002572 ID - Cui2016 ER - TY - JOUR AU - Sylvester, R. J. AU - Brausi, M. A. AU - Kirkels, W. J. AU - Hoeltl, W. AU - Calais Da Silva, F. AU - Powell, P. H. PY - 2010 DA - 2010// TI - Long-term efficacy results of EORTC genito-urinary group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guerin, and bacillus Calmette-Guerin plus isoniazid in patients with intermediate- and high-risk stage Ta T1 urothelial carcinoma of the bladder JO - Eur Urol VL - 57 UR - https://doi.org/10.1016/j.eururo.2009.12.024 DO - 10.1016/j.eururo.2009.12.024 ID - Sylvester2010 ER - TY - JOUR AU - Arends, T. J. H. AU - Witjes, J. A. PY - 2016 DA - 2016// TI - Results of a randomised controlled trial comparing Intravesical Chemohyperthermia with Mitomycin C versus Bacillus Calmette-Guerin for adjuvant treatment of patients with intermediate- and high-risk non-muscle-invasive bladder Cancer JO - Eur Urol VL - 69 UR - https://doi.org/10.1016/j.eururo.2016.01.006 DO - 10.1016/j.eururo.2016.01.006 ID - Arends2016 ER - TY - JOUR AU - Stasi, S. M. AU - Valenti, M. AU - Verri, C. AU - Liberati, E. AU - Giurioli, A. AU - Leprini, G. PY - 2011 DA - 2011// TI - Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: A randomised controlled trial JO - Lancet Oncol VL - 12 UR - https://doi.org/10.1016/S1470-2045(11)70190-5 DO - 10.1016/S1470-2045(11)70190-5 ID - Stasi2011 ER -